Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Is The Projected Valuation Of The Albumin Market In The Coming Years?

In recent times, the albumin market has experienced robust growth. The market, which was worth $6.57 billion in 2024, is projected to swell to $7.16 billion in 2025, representing a compound annual growth rate (CAGR) of 9.0%. The earlier growth phase was facilitated by progressive strides in biotechnological research, a burgeoning demand for therapies derived from plasma, wider usage in pharmaceutical sectors, high incidence of liver disorders, regulatory green-lights for albumin-centric products, and the universalization of healthcare, which has broadened market accessibility.

In the coming years, the albumin market is anticipated to undergo robust expansion and is projected to reach a valuation of $9.93 billion by 2029, progressing at a CAGR of 8.5%. This forecasted growth can be ascribed to various factors including a surge in liver disease cases, burgeoning applications in the field of regenerative medicine, an ageing population, advancements in diagnostic protocols, a shift in healthcare setting towards outpatient care, and increased cognizance about the significance of maintaining appropriate protein levels. Additionally, the market is guided by trends in the forecast period such as diversified therapeutic uses, amplified incorporation in drug delivery systems, escalating requirements in cell culture media, growth in custom-tailored medicine, progress in recombinant technology, enhanced awareness about the treatment of hypoalbuminemia, and considerable financial input into R&D for the innovation of albumin-based commodities.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16333&type=smp

What Drivers Are Accelerating Expansion Of The Albumin Market?

The increasing cases of diabetes are anticipated to fuel the expansion of the albumin market in the future. Characterized by elevated blood sugar levels over an extended period, diabetes is a metabolic disorder. This condition is growing due to unhealthy eating habits, insufficient physical exercise, hormonal disorders, and obesity. Albumin serves as a significant biomarker in diabetes, playing a pivotal role in guiding insulin therapy, supervising glycemic control, aiding in diagnosis, and predicting potential complications like diabetic ketoacidosis (DKA). It’s vital to maintain regular albumin levels for effective diabetes management. For example, the National Library of Medicine, a government library based in the US, reported in January 2022 that in 2021, the global diabetes prevalence was roughly 10.5%, affecting about 536.6 million individuals between the ages of 20 and 79. By 2045, this number is predicted to rise to 12.2%, affecting nearly 783.2 million individuals. Thus, the increasing occurrence of diabetes is anticipated to stimulate the expansion of the albumin market in the future.

How Is The Global Albumin Market Broken Down By Segment?

The albuminmarket covered in this report is segmented –

1) By Type: Human Serum Albumin; Bovine Serum Albumin; Recombinant Albumin

2) By Application: Therapeutics; Drug Formulation And Vaccines; Component Of Media; Other Applications

3) By Sales Channel: Business-To-Consumer (B2C); Business-To-Business (B2B)

4) By End-User: Hospitals And Clinics; Pharmaceutical And Biotechnology Companies; Research Institutes

Subsegments:

1) By Human Serum Albumin: Plasma-Derived Human Serum Albumin; Recombinant Human Serum Albumin; Human Serum Albumin For Therapeutic Use (In Liver Disease, Burns); Human Serum Albumin For Drug Delivery And Research Applications

2) By Bovine Serum Albumin: Bovine Serum Albumin For Laboratory Use (In Cell Culture); Bovine Serum Albumin For Diagnostic Kits; Bovine Serum Albumin As A Stabilizer In Vaccines And Biopharmaceuticals

3) By Recombinant Albumin: Recombinant Human Albumin For Therapeutic Applications; Recombinant Albumin For Biopharmaceutical Formulation; Recombinant Albumin For Cosmetic And Personal Care Applications; Recombinant Albumin For Research And Diagnostic Applications

Which Trends Are Likely To Redefine Growth Paths In The Albumin Market?

Significant industry players in the albumin market are enhancing their product offerings by introducing novel products like the animal-and human-origin-free recombinant albumin, aiming to satisfy their customer base with superior characteristics. The animal- and human-origin-free recombinant albumin is unique in its production, utilizing non-mammalian sources such as yeast and devoid of any constituents derived from animal or human sources. A key example is the partnership formed in March 2023 by Albumedix, a UK manufacturer of recombinant human albumin (rHA), and Japan’s clinical-stage biotech outfit, Heartseed Inc. They worked together to introduce Recombin, a crucial excipient for Heartseed’s investigational cell therapy product, HS-001, as the first human clinical trial commences. This partnership signifies a pivotal step towards the progression of HS-001, with potential to transform various disease treatments. By incorporating recombination in its manufacturing process, the therapy’s optimum function and stability are ensured, further cementing its therapeutic success probabilities.

Which Firms Are Making The Biggest Impact In The Albumin Market?

Major companies operating in the albumin market are Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Takeda Pharmaceutical Company Limited, Merck KGaA, Baxter International Inc., CSL Limited, Grifols SA, Mitsubishi Tanabe Pharma Corporation, Octapharma AG, Kedrion S.p.A., Biotest AG, Jiangxi Boya Bio-Pharmaceutical Co. Ltd., BPL (Bio Products Laboratory), Kamada Ltd., Proliant Biologicals, SeraCare Life Sciences Inc., HiMedia Laboratories, Albumedix Ltd., Medxbio Pte Ltd., Ventria Bioscience Inc., China Biologic Products Holdings Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/albumin-global-market-report

Which Geographic Regions Are Creating Strong Demand In The Albumin Market?

North America was the largest region in the albumin market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the albumin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=16333&type=smp

Browse Through More Reports Similar to the Global Albumin Market 2025, By The Business Research Company

Stem Cell Assay Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/stem-cell-assay-global-market-report

Glycomics Or Glycobiology Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/glycomics-or-glycobiology-global-market-report

Hospital Capacity Management Solutions Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hospital-capacity-management-solutions-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model